Marathon Capital Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,540
Closed -$1.12M 147
2022
Q1
$1.12M Sell
19,540
-11
-0.1% -$562 0.32% 56
2021
Q4
$924K Sell
19,551
-2,492
-11% -$113K 0.22% 69
2021
Q3
$928K Buy
22,043
+3,560
+19% +$154K 0.21% 69
2021
Q2
$819K Sell
18,483
-2,072
-10% -$95.7K 0.19% 67
2021
Q1
$958K Sell
20,555
-2,672
-12% -$118K 0.25% 58
2020
Q4
$899K Sell
23,227
-1,100
-5% -$39.3K 0.27% 59
2020
Q3
$700K Sell
24,327
-2,540
-9% -$71.5K 0.25% 59
2020
Q2
$720K Sell
26,867
-1,211
-4% -$31.5K 0.28% 55
2020
Q1
$659K Buy
28,078
+359
+1% +$9.87K 0.3% 52
2019
Q4
$819K Buy
27,719
+4,405
+19% +$117K 0.28% 58
2019
Q3
$653K Buy
23,314
+4,544
+24% +$131K 0.26% 52
2019
Q2
$555K Buy
+18,770
New +$505K 0.23% 58

Other funds holding CTVA

Marathon Capital Management's CTVA Position: Q2 2022 in Review

Marathon Capital Management sold out of Corteva (CTVA) in Q2 2022, closing a stake of 19,540 shares — an estimated $1.12M sold.

Marathon Capital Management first reported a position in CTVA in Q2 2019 and held it in 12 quarters. The position peaked at $1.12M in Q1 2022. 1,190 funds tracked by Wall St. Rank hold CTVA as of Q2 2022.

  • Marathon Capital Management reported no remaining Corteva position as of Q2 2022 after selling out during the quarter.
  • Marathon Capital Management sold 19,540 Corteva shares in Q2 2022, an estimated $1.12M.
  • Marathon Capital Management first reported a position in Corteva in Q2 2019 and held it in 12 quarters.
  • Marathon Capital Management's Corteva position peaked at $1.12M in Q1 2022.
  • 1,190 funds tracked by Wall St. Rank held Corteva as of Q2 2022.

Based on Marathon Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.